You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Cutaneous Lupus

Showing 26 - 50 of 2,631
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Discoid Lupus Erythematosus Trial in New York (CC-10004)

Completed
Has Results
  • Discoid Lupus Erythematosus
  • New York, New York
    New York University Tisch Hospital
Feb 10, 2021

Lupus Erythematosus, Cutaneous, Lupus Erythematosus, Discoid, Lupus Erythematosus, Systemic Trial in West Hollywood

Completed
  • Lupus Erythematosus, Cutaneous
  • +4 more
  • West Hollywood, California
    Cedars Sinai Medical Center-Wallace Rheumatic Study Center
Aug 12, 2021

Systemic Lupus Erythematosus, Cutaneous Lupus Erythematosus, Sjogren's Syndrome Trial in Poland, Spain, United States (VIB7734,

Completed
  • Systemic Lupus Erythematosus
  • +5 more
  • Anniston, Alabama
  • +29 more
Aug 11, 2020

Cutaneous Lupus Erythematosus Trial in Canada, United States (Lanraplenib, Filgotinib, Lanraplenib )

Completed
Has Results
  • Cutaneous Lupus Erythematosus
  • Beverly Hills, California
  • +15 more
Jun 1, 2020

Systemic Lupus Erythematosus Trial in Worldwide (M5049 low dose, M5049 medium dose, M5049 high dose)

Not yet recruiting
  • Systemic Lupus Erythematosus
  • M5049 low dose
  • +3 more
  • Scottsdale, Arizona
  • +160 more
Sep 12, 2022

Systemic Lupus Erythematosus Trial in Worldwide (M5049 low dose, M5049 medium dose, M5049 high dose)

Recruiting
  • Systemic Lupus Erythematosus
  • M5049 low dose
  • +3 more
  • Torrance, California
  • +60 more
Aug 22, 2022

Cutaneous Lupus Erythematosus (CLE) Trial in Philadelphia (Lenalidomide)

Completed
Has Results
  • Cutaneous Lupus Erythematosus (CLE)
  • Philadelphia, Pennsylvania
    Hospital of the University of Pennsylvania, Department of Dermat
Oct 24, 2019

Discoid Lupus Erythematosus Trial in Cairo (Nicotinamide Topical)

Completed
  • Discoid Lupus Erythematosus
  • Nicotinamide Topical
  • Cairo, Egypt
    AL-Azhar University Hospital
Oct 22, 2022

Lupus Erythematosus, Cutaneous, Lupus Erythematosus, Discoid, Lupus Erythematosus, Systemic Trial in San Francisco (Ex vivo

Terminated
Has Results
  • Lupus Erythematosus, Cutaneous
  • +2 more
  • Ex vivo Expanded Human Autologous Polyclonal Regulatory T Cells
  • San Francisco, California
    University of California, San Francisco
Oct 22, 2019

Discoid Lupus Erythematosus Trial in Canada, United States (Placebo/Daxdilimab, Daxdilimab)

Recruiting
  • Discoid Lupus Erythematosus
  • North Little Rock, Arkansas
  • +21 more
Jan 17, 2023

Lupus Erythematosus, Systemic Trial in Beijing (low dose GR1603 in phase ?b, high dose GR1603 in phase?b, low dose GR1603 in

Recruiting
  • Lupus Erythematosus, Systemic
  • low dose GR1603 in phase Ⅰb
  • +4 more
  • Beijing, Beijing, China
    Peking union Medical Hosipital
Aug 22, 2023

Systemic Lupus Erythematosus Trial (GLPG3667, Placebo)

Not yet recruiting
  • Systemic Lupus Erythematosus
  • (no location specified)
May 4, 2023

Systemic Lupus Erythematosus, Active Cutaneous Lupus Erythematosus Trial in Worldwide (BIIB059, Placebo)

Completed
  • Systemic Lupus Erythematosus
  • Active Cutaneous Lupus Erythematosus
  • Anniston, Alabama
  • +128 more
Aug 27, 2020

Systemic Lupus Erythematosus Trial in Mainz (Exercise)

Completed
  • Systemic Lupus Erythematosus
  • Exercise
  • Mainz, Rheinland-Pfalz, Germany
    UNIVERSITÄTSMEDIZIN der Johannes Gutenberg-Universität Mainz I.
Nov 5, 2022

Discoid Lupus Erythematosus Trial in Rochester (Ruxolitinib)

Enrolling by invitation
  • Discoid Lupus Erythematosus
  • Rochester, New York
    UR Medicine Dermatology College Town
May 20, 2022

Duke Autoimmunity in Pregnancy Registry

Completed
  • Pregnancy
  • +5 more
    • Durham, North Carolina
      Duke University Medical Center
    Oct 21, 2019

    Lupus Erythematosus, Systemic Trial in Worldwide (Placebo, Ustekinumab (approximately 6 mg/kg), Ustekinumab 90 mg)

    Terminated
    Has Results
    • Lupus Erythematosus, Systemic
    • Placebo
    • +2 more
    • Anniston, Alabama
    • +203 more
    Jan 31, 2023

    Lupus Erythematosus, Systemic Trial in Worldwide (BIIB059, BIIB059 matching )

    Recruiting
    • Lupus Erythematosus, Systemic
    • Upland, California
    • +41 more
    Apr 19, 2022

    Systemic Lupus Erythematosus Trial in Worldwide (Placebo, Nipocalimab, Standard-of-care treatment)

    Recruiting
    • Systemic Lupus Erythematosus
    • Placebo
    • +2 more
    • Los Alamitos, California
    • +101 more
    Aug 4, 2022

    Autoimmune Disorder, Rheumatoid Arthritis, Systemic Lupus Erythematosus Trial in Worldwide (branebrutinib, abatacept,

    Completed
    • Autoimmune Disorder
    • +3 more
    • Phoenix, Arizona
    • +80 more
    Dec 16, 2022

    Systemic Lupus Erythematosus Trial in Brest (description of a lupus patient cohort)

    Recruiting
    • Systemic Lupus Erythematosus
    • description of a lupus patient cohort
    • Brest, France
      CHRU de Brest
    Jan 24, 2022

    Active Systemic Lupus Erythematosus Trial in Worldwide (Anifrolumab, )

    Recruiting
    • Active Systemic Lupus Erythematosus
    • Anifrolumab
    • placebo
    • Baoding, China
    • +71 more
    Jan 13, 2023

    Systemic Lupus Erythematosus Trial in Worldwide (Deucravacitinib, Placebo)

    Recruiting
    • Systemic Lupus Erythematosus
    • Anniston, Alabama
    • +88 more
    Jan 25, 2023

    Systemic Lupus Erythematosus Trial in Worldwide (Deucravacitinib, Placebo)

    Recruiting
    • Systemic Lupus Erythematosus
    • La Jolla, California
    • +91 more
    Jan 24, 2023

    Inflammatory Disease, Autoimmune Diseases Trial in Paris (Kineret, Humira, Stelara)

    Recruiting
    • Inflammatory Disease
    • Autoimmune Diseases
    • Paris, France
      Hôpital Cochin
    Oct 10, 2022